MedPath

Calosyn Pharma, Inc.

Calosyn Pharma, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2007-09-01
Employees
1
Market Cap
-
Website
http://calosynpharma.com

Safety, Tolerability, and Efficacy of IA Verapamil in the Treatment of Joint Pain in Subjects With Osteoarthritis of the Knee

Phase 1
Terminated
Conditions
Osteoarthritis of the Knee
Interventions
Drug: Verapamil
Drug: Placebo
First Posted Date
2012-07-20
Last Posted Date
2014-09-05
Lead Sponsor
Calosyn Pharma, Inc.
Target Recruit Count
81
Registration Number
NCT01645709
© Copyright 2025. All Rights Reserved by MedPath